Dividend
-
-
-
-
-
-
-
Beam Therapeutics Provides Business and Pipeline Updates and Reports Second Quarter 2021 Financial Results
-
-
-
-
-
-
-
Beam Therapeutics Announces First Development Candidates for Sickle Cell Disease and Reports Second Quarter 2020 Results
-
-
-
-
-
-
-
Top 10 News for 01/13 - 01/17: Tesla Back in Favor; Shoppers Shun Best Buy; Nesting at Google
-
-
-
-
-
-
-
Beam, Inc. (BEAM) Declares $0.205 Quarterly Dividend; 1.4% Yield
-
-
-
436,668 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

